Aichi, Japan

Yasuhiro Iwata

This inventor holds 14 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignees: Nippondenso Co., Ltd., Raqualia Pharma Inc., Askat Inc.. Active years: 1981-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuhiro Iwata. Retrieved from https://idiyas.com/inventor/yasuhiro-iwata-7i4ju4uw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.6

ph-index = 8

Forward Citations = 112(Granted Patents)


Company Filing History:


Years Active: 1981-2026

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Yasuhiro Iwata: Innovator in Ghrelin Receptor Agonists

Introduction

Yasuhiro Iwata is a prominent inventor based in Aichi, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that act as ghrelin receptor agonists. With a total of 14 patents to his name, Iwata's work has the potential to impact therapeutic approaches for various disorders.

Latest Patents

Among his latest patents, Iwata has developed novel compounds such as Tetrahydropyrazolopyridine derivatives and Serine derivatives. The Tetrahydropyrazolopyridine derivatives are described as compounds that can modulate the growth hormone secretagogue receptor, also known as the ghrelin receptor. This invention includes processes for their preparation, pharmaceutical compositions, and their therapeutic uses. Similarly, the Serine derivatives also target the ghrelin receptor, offering potential treatment options for disorders mediated by this receptor.

Career Highlights

Iwata has worked with notable companies in the pharmaceutical industry, including Nippondenso Co., Ltd. and Raqualia Pharma Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Iwata has collaborated with esteemed colleagues such as Kiyoshi Usami and Masanori Naganoma. These partnerships have likely enhanced his research and development efforts in the field.

Conclusion

Yasuhiro Iwata's innovative work in the area of ghrelin receptor agonists showcases his dedication to advancing pharmaceutical science. His contributions through numerous patents reflect his commitment to improving therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…